Chimerix reported $0 in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Ardelyx ARDX:US $ 26.37M 0.23M
Chimerix CMRX:US $ 0M 0M
Curis CRIS:US $ 0M 0M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Emergent Biosolutions EBS:US $ 825.2M 7.9M
Epizyme EPZM:US $ 232.9M 0.41M
Glaxosmithkline GSK:US $ 22111M 11217M
Life Technologies LIFE:US $ 0.37M 0.37M
Mirati Therapeutics MRTX:US $ 0M 0M
Novavax NVAX:US $ 448.43M 7.93M
Xoma XOMA:US $ 0 0